Buyback17 Apr 2026, 02:03 pm
Windlas Biotech Board Approves ₹47 Cr Buyback of 4.7 Lakh Shares at ₹1,000/Share
AI Summary
Windlas Biotech Ltd's Board of Directors has approved a proposal for the buyback of up to 4,70,000 fully paid-up equity shares, each with a face value of ₹5.00. This represents 2.23% of the company's total equity shares. The maximum buyback size is set at ₹47 crore, with a buyback price of ₹1,000 per equity share, payable in cash. The buyback will be conducted through a tender offer, excluding promoters and promoter group members, with 15% reserved for small shareholders. Promoters have indicated they will not participate. The record date for determining eligible shareholders has been fixed as Friday, April 24, 2026.
Key Highlights
- Board approved buyback of up to 4,70,000 equity shares.
- Buyback size is ₹47 crore at a price of ₹1,000 per share.
- Represents 2.23% of the company's total equity shares.
- Buyback via tender offer; promoters will not participate.
- Record date for eligibility is April 24, 2026.